CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial in India for Sintilimab Injection Before Moving to Phase III
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has advised Mankind Pharma to initiate a […]
